Thirdwayv Technology Powers FDA-Authorized Glas G2 Platform
IRVINE, California, USA – June 8, 2026 Thirdwayv Inc. has highlighted the role of its advanced age-gating and authentication...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
IRVINE, California, USA – June 8, 2026 Thirdwayv Inc. has highlighted the role of its advanced age-gating and authentication...
SILVER SPRING, Md., May 20, 2026 The U.S. Food and Drug Administration (FDA) has intensified its enforcement efforts against...
PHOENIX | January 6, 2026 — Sunbelt Bakery has unveiled a new packaging design for its consumer snack products,...
NEW YORK, Dec. 28, 2025 — Remedy Science, a dermatologist-founded skincare brand created by Dr. Muneeb Shah, has launched...
